Editorial & Columns Reporting on Scope 3 Emissions: Learning from Global Pharmaceutical MNCs August 21, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Blueprint for Sustained Growth in Rural India August 20, 2024 | Satish Singh | No Comments | More
Editorial & Columns Hostages’ Release Awaited: The US and China Team Up for an Imminent Peace in West Asia August 20, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Transparency key to uphold SEBI’s trust August 17, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Two-Nation Rhetoric Reinvented: Pak Army Hopes to Claim Intimate Ties with Pro-Islamists Regime in Dacca August 14, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Different Routes and Same Destination: Indian Pharmaceutical & FMCG Companies in Wellness Segment August 14, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns In Perfect Balance-Inflation and Development August 14, 2024 | Satish Singh | No Comments | More
Editorial & Columns Delhi remains vulnerable to Centre’s wishes August 10, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Army’s Renewed Role :Muhammad Yunus Becomes the Face of the Hybrid Regime in Dacca August 6, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Risk Management and Pharmaceutical Companies in India August 6, 2024 | Dr. Anil Kumar Angrish | No Comments | More